MARY KLUNICK: Open Payments
NPI 1083130298 · SPRINGFIELD, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$788 in 30 payments from 9 companies in 2025. Trend: 2023 $627 · 2024 $760 · 2025 $788
Food & beverage: $711Education: $77
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $376 |
| Madrigal Pharmaceuticals | 2 | $183 |
| Janssen Biotech, Inc. | 1 | $77 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $52 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $35 |
| Intercept Pharmaceuticals, Inc. | 1 | $18 |
| Phathom Pharmaceuticals, Inc. | 1 | $18 |
| Ardelyx, Inc. | 1 | $15 |
| Aimmune Therapeutics, Inc. | 1 | $14 |
Products named: REZDIFFRA, SKYRIZI, TREMFYA, XIFAXAN, RINVOQ, LINZESS, EOHILIA, CREON.
Industry payments across IL — which companies pay providers there.
